Vetoquinol (France) Today
| VETO Stock | EUR 78.30 0.60 0.76% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Vetoquinol is trading at 78.30 as of the 22nd of November 2024, a 0.76 percent decrease since the beginning of the trading day. The stock's open price was 78.9. Vetoquinol has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Vetoquinol are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. Vetoquinol SA was founded in 1933 and is headquartered in Lure, France. Vetoquinol operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. The company has 11.88 M outstanding shares. More on Vetoquinol
Moving against Vetoquinol Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Vetoquinol Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Vetoquinol's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Vetoquinol or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Matthieu Frechin |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers - Major, Healthcare (View all Sectors) |
Vetoquinol (VETO) is traded on Euronext Paris in France and employs 2,621 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 951.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vetoquinol's market, we take the total number of its shares issued and multiply it by Vetoquinol's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Vetoquinol operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 11.88 M outstanding shares.
Vetoquinol has accumulated about 117.63 M in cash with 89.72 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.93.
Check Vetoquinol Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Vetoquinol is €951.74 Million. Vetoquinol has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 66.9 % of Vetoquinol outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with substantial debt, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
Check Vetoquinol Ownership Details
Vetoquinol Risk Profiles
Although Vetoquinol's alpha and beta are two of the key measurements used to evaluate Vetoquinol's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.32 | |||
| Standard Deviation | 1.83 | |||
| Variance | 3.34 | |||
| Risk Adjusted Performance | (0.09) |
Vetoquinol Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vetoquinol without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Vetoquinol Corporate Directors
| Hans Hollegien | Member of the Executive Committee, Group Director - Marketing and Communication | Profile | |
| Isabelle ProustCabrera | Member of the Executive Committee, Group Director - Human Resources | Profile | |
| Dominique Derveaux | Member of the Executive Committee, Group Director - Europe | Profile | |
| Regis Monteil | Group Director of Fin. and Legal | Profile |
Other Information on Investing in Vetoquinol Stock
Vetoquinol financial ratios help investors to determine whether Vetoquinol Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vetoquinol with respect to the benefits of owning Vetoquinol security.